By Eleanor Garth – Longevity.Technology –
LongeVC’s Sergey Jakimov says longevity needs to demystify, be understandable and be ready to use in healthcare.
LongeVC is a Switzerland-based venture capital company that supports early-stage biotech and longevity-focused founders and startups. Its founding partner, entrepreneur Sergey Jakimov, takes his responsibility to the sector seriously, and while he is keen to help shape the future of longevity biotech, he is equally focused on keeping a weather eye on the ethical implications of biotech and longevity-focused initiatives.
